|
![]() |
|||
|
||||
OverviewIn India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable Full Product DetailsAuthor: P. MalhotraPublisher: Palgrave Macmillan Imprint: Palgrave Macmillan Dimensions: Width: 15.20cm , Height: 2.00cm , Length: 22.90cm Weight: 0.643kg ISBN: 9780230272781ISBN 10: 0230272789 Pages: 320 Publication Date: 13 October 2010 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsForeword Acknowledgments Introduction PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES The World Trade Organization and the TRIPS Agreement The Global Pharmaceutical Industry and Developing New Drugs PART II: ACCESS TO MEDICINES IN INDIA Development of India's Pharmaceutical Industry TRIPS and the Indian Patents Regime Price Controls and Drug Affordability in India: Policy Options Health Insurance in India Broadening the Access to Medicines and Healthcare in India PART III: GLOBAL PERSPECTIVE Is TRIPS Appropriate for Developing Countries? Which Way Ahead? Final Conclusions ReferencesReviewsAuthor InformationPRABODH MALHOTRA was born and brought up in India but has been living in Australia since 1980. Thus, he understands both systems. He has taught at a number of universities in Australia. Prabodh has PhD in Economics and Masters in International Business and has published conference papers, journal articles and government reports in these areas. This book is based on his extensive research and fieldwork in India. Tab Content 6Author Website:Countries AvailableAll regions |